C4 Therapeutics, a clinical-stage biopharmaceutical company focused on targeted protein degradation, announced its management will participate in two key investor events in November 2026. The company will join a fireside chat at the Guggenheim Healthcare Innovation Conference on November 9 in Boston and present at the Jefferies Global Healthcare Conference on November 17 in London. These events provide C4 Therapeutics an opportunity to showcase its progress in developing novel medicines for difficult-to-treat diseases using its TORPEDO® platform. Live webcasts and archived replays will be available on the company's website, allowing investors to follow updates remotely.
C4 Therapeutics' upcoming investor conference participation is noted alongside a snapshot of health sector trading on Pluang. For readers following health stocks, here is Pluang's market snapshot as of Nov 03, 2026 19:02 WIB: Out of 150 priced US health-sector stocks, 74 rose and 69 fell. Notable movers include INO at USD 1.78 with a 5.56% decline and a Pluang order activity of 51% Sell / 49% Buy, NUWE at USD 4.90 down 5.41% with 45% Sell / 55% Buy, and AHCO at USD 6.20 up 4.91% with 10% Sell / 90% Buy. Typical hold times range from 21 to 42 days.
Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...
Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...
Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...
Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...
Stella-Jones Inc. announced a conference call for November 4, 2026, at 10:00 AM EST to discuss its third quarter 2026 financial results. The call is open to investors, analysts, and interested parties and will be webcast live with a recording availab...
